Literature DB >> 2846453

Large scale production and purification of paraquat and desipramine monoclonal antibodies and their Fab fragments.

M Bowles1, S C Johnston, D D Schoof, P R Pentel, S M Pond.   

Abstract

We describe the rapid, large scale purification of Fab fragments from mouse monoclonal antibodies. Antibodies against two clinically important and often fatal toxins, paraquat and desipramine, were isolated from mouse ascites fluid by preparative high performance hydroxylapatite (HPHT) or ion exchange (DEAE) high performance liquid chromatography. A competitive inhibition ELISA was used to determine the cross-reactivity of the antibody with analogs of the antigens. Papain digests of the IgGs were subjected to further HPHT followed by Sephadex G-100 chromatography to yield homogeneous Fab fragment preparations. The high purity of these preparations, demonstrated by SDS polyacrylamide gel electrophoresis, has only been achieved previously by affinity chromatography. Intrinsic association constants for the intact IgG and the Fab fragment--antigen interactions, determined by competitive inhibition ELISA, were similar. This indicates that antigen-binding activity was conserved during the production and purification of the Fab fragments.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2846453     DOI: 10.1016/0192-0561(88)90071-9

Source DB:  PubMed          Journal:  Int J Immunopharmacol        ISSN: 0192-0561


  6 in total

1.  Cooperative multimodal retention of IgG, fragments, and aggregates on hydroxyapatite.

Authors:  Pete Gagnon; Chia-Wei Cheung; Paul J Yazaki
Journal:  J Sep Sci       Date:  2009-11       Impact factor: 3.645

2.  Minibodies and Multimodal Chromatography Methods: A Convergence of Challenge and Opportunity.

Authors:  Pete Gagnon; Chia-Wei Cheung; Eric J Lepin; Anna M Wu; Mark A Sherman; Andrew A Raubitschek; Paul J Yazaki
Journal:  Bioprocess Int       Date:  2010-02

Review 3.  Fab antibody fragments: some applications in clinical toxicology.

Authors:  Robert J Flanagan; Alison L Jones
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

4.  Analytical control procedures of immunoreactivity for IgG and Fab fragments specific to haptens.

Authors:  N J Cano; A E Sabouraud; M Urtizberea; J Carcagne; M Grandgeorge; J M Scherrmann
Journal:  Pharm Res       Date:  1992-05       Impact factor: 4.200

5.  Reverse calcium affinity purification of Fab with calcium derivatized hydroxyapatite.

Authors:  Pete Gagnon; Chia-Wei Cheung; Paul J Yazaki
Journal:  J Immunol Methods       Date:  2009-01-14       Impact factor: 2.303

6.  High efficiency reduction capability for the formation of Fab׳ antibody fragments from F(ab)2 units.

Authors:  Victor Crivianu-Gaita; Alexander Romaschin; Michael Thompson
Journal:  Biochem Biophys Rep       Date:  2015-04-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.